Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation

Post-translational modifications (PTMs) of histone proteins are a hallmark of epigenetic regulation. They provide a mechanism to modulate chromatin structure and constitute the main features of the so-called “histone code”.1 The proposed function of this code is to integrate exogenous and endogenous signals into a diverse set of histone PTM patterns to enable the epigenetic control of gene expression. The key regulators of this process are the so-called “writers” and “erasers”, which act by dynamically modifying histones, and other chromatin-associated proteins, as well as the “readers”, which interpret these PTMs, thereby facilitating the downstream activation or repression of gene expression.2 The writers are histone-modifying enzymes that can be grouped according to their amino acid substrate preference, affecting mainly lysine, arginine, and serine residues.3 These enzymes can be further classified according to the type of covalent modification that they catalyze. Histone modifications include acetylation, methylation, phosphorylation, and the more recently described modifications of citrullination, ubiquitination, SUMOylation, proline isomerization, O-GlcNAcylation, and ADP-ribosylation.1b,3 On the basis of detailed mass spectrometric analyses, there are at least 15 different types of covalent histone modifications,4 and since histone proteins are modified at multiple sites, and different stoichiometries, the total number of histone marks is >160.5 Although our understanding of how histone modifications contribute to the epigenetic control of gene transcription has grown immensely over the past ∼15 years, the precise impact of this vast number of modifications, not to mention the crosstalk between them, has yet to be fully realized. Histone proteins are small, highly basic proteins consisting of a globular domain and flexible N-terminal and C-terminal tails that protrude from the nucleosome. The core histone proteins (histones H2A, H2B, H3, and H4) form an octameric particle consisting of two H2A–H2B dimers and an H3–H4 tetramer, around which wrap two helical turns of DNA (∼150 bp).6 This structure, which is generally termed a nucleosome, comprises the basic building block of higher order chromatin structures that are further organized through the function of linker histones such as histone H1. On the basis of nucleosome positioning studies, around 80% of the yeast genome and even 99% of the mappable genome of human granulocytes is occupied by nucleosomes, thereby highlighting the importance of nucleosome-packaged DNA for eukaryotic cells.7 Importantly, while histone PTMs are found throughout the entire protein, they are most often clustered within the N-terminal tail. Although research on histone lysine modifications has drawn considerable attention and even resulted in the approval of novel anticancer drugs,8 the modification of histone arginine residues is a recently emerging nucleosomal mark of similar importance (Figure ​(Figure11). Figure 1 N-terminal tails of histone proteins are the preferred targets of histone-modifying enzymes. The major modifications of histone arginine residues are citrullination and methylation. Abbreviations: Cit, citrulline; MMA, monomethylarginine; ADMA, asymmetric ...

[1]  Xinbin Chen,et al.  PRMT5 is required for cell-cycle progression and p53 tumor suppressor function , 2009, Nucleic acids research.

[2]  C. Allis,et al.  Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation , 2009, The Journal of cell biology.

[3]  M. Surani,et al.  Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. , 2010, Genes & development.

[4]  I. Newsham,et al.  DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo , 2004, Oncogene.

[5]  P. Thompson,et al.  Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? , 2006, ACS chemical biology.

[6]  D. Hwang Cation-π Interaction , 2013 .

[7]  Xiaodong Cheng,et al.  Surface-scanning mutational analysis of protein arginine methyltransferase 1: roles of specific amino acids in methyltransferase substrate specificity, oligomerization, and coactivator function. , 2007, Molecular endocrinology.

[8]  D. Wagner,et al.  VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. , 2014, Blood.

[9]  Yuan Luo,et al.  Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe. , 2006, Journal of the American Chemical Society.

[10]  S. Pang,et al.  Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies. , 2009, Bioorganic & medicinal chemistry letters.

[11]  S. Clarke,et al.  Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions* , 2013, The Journal of Biological Chemistry.

[12]  A. Ishigami,et al.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. , 2003, The Biochemical journal.

[13]  Remco Loos,et al.  Citrullination regulates pluripotency and histone H1 binding to chromatin , 2014, Nature.

[14]  J. Workman,et al.  In and out: histone variant exchange in chromatin. , 2005, Trends in biochemical sciences.

[15]  C. Werning [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.

[16]  A. Kawada,et al.  Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. , 2004, Gene.

[17]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[18]  C. Ackerley,et al.  Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. , 1996, The Journal of clinical investigation.

[19]  P. Thompson,et al.  Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms , 2011 .

[20]  M. Shirakawa,et al.  Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX–DNMT3–DNMT3L domain , 2009, EMBO reports.

[21]  A. Ishigami,et al.  Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. , 2002, Archives of biochemistry and biophysics.

[22]  K. Mizuguchi,et al.  The guanidino‐group modifying enzymes: Structural basis for their diversity and commonality , 2006, Proteins.

[23]  T. Pawson,et al.  Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain , 2010, Proceedings of the National Academy of Sciences.

[24]  S. Coonrod,et al.  Potential Role for Peptidylarginine Deiminase 2 (PAD2) in Citrullination of Canine Mammary Epithelial Cell Histones , 2010, PloS one.

[25]  P. Thompson,et al.  In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1. , 2008, Journal of the American Chemical Society.

[26]  M. Uffmann,et al.  Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. , 2006, Rheumatology.

[27]  L. Pearl,et al.  Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase , 2007, The EMBO journal.

[28]  P. Thompson,et al.  The protein arginine deiminases: Structure, function, inhibition, and disease. , 2013, Biopolymers.

[29]  X. Chang,et al.  Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors , 2010, International journal of biological sciences.

[30]  Michael Sattler,et al.  High-resolution X-ray and NMR structures of the SMN Tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues. , 2003, Journal of molecular biology.

[31]  E. Charpentier,et al.  Structural basis for recognizing phosphoarginine and evolving residue-specific protein phosphatases in gram-positive bacteria. , 2013, Cell reports.

[32]  P. Thompson,et al.  Substrate specificity, processivity, and kinetic mechanism of protein arginine methyltransferase 5. , 2013, Biochemistry.

[33]  Claudio Agostinelli,et al.  Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. , 2015, Blood.

[34]  P. Thompson,et al.  Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity. , 2011, Biochemistry.

[35]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[36]  G. Rosen,et al.  Mechanism of Superoxide Generation by Neuronal Nitric-oxide Synthase* , 1999, The Journal of Biological Chemistry.

[37]  R. Braren,et al.  The family of toxin‐related ecto‐ADP‐ribosyltransferases in humans and the mouse , 2002, Protein science : a publication of the Protein Society.

[38]  Thomas W. Linsky,et al.  Mechanistic similarity and diversity among the guanidine-modifying members of the pentein superfamily. , 2010, Biochimica et biophysica acta.

[39]  A. D. Clark,et al.  Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. , 2004, Structure.

[40]  Pojen P. Chen,et al.  NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis , 2013, Science Translational Medicine.

[41]  N. Martin,et al.  Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites. , 2015, Organic & biomolecular chemistry.

[42]  Kürşad Turgay,et al.  Global impact of protein arginine phosphorylation on the physiology of Bacillus subtilis , 2012, Proceedings of the National Academy of Sciences.

[43]  S. Arandjelovic,et al.  PAD4-Mediated Neutrophil Extracellular Trap Formation Is Not Required for Immunity against Influenza Infection , 2011, PloS one.

[44]  C. Briand,et al.  Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors. , 2006, Structure.

[45]  D. Boger,et al.  Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation. , 2014, Bioorganic & medicinal chemistry.

[46]  S. Richard,et al.  Arginine Methylation of the Histone H3 Tail Impedes Effector Binding* , 2008, Journal of Biological Chemistry.

[47]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[48]  Zhike Lu,et al.  Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification , 2011, Cell.

[49]  G. Dreyfuss,et al.  SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. , 2001, Molecular cell.

[50]  Xiangli Cui,et al.  D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy. , 2012, ACS medicinal chemistry letters.

[51]  K. Kish,et al.  Structural basis for CARM1 inhibition by indole and pyrazole inhibitors. , 2011, The Biochemical journal.

[52]  J. Hazes,et al.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.

[53]  Andrew J. Bannister,et al.  Histone Methylation Dynamic or Static? , 2002, Cell.

[54]  K. O. Elliston,et al.  Chemogenetic Analysis of Human Protein Methyltransferases , 2011, Chemical biology & drug design.

[55]  Yuan Luo,et al.  Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4. , 2011, ACS chemical biology.

[56]  P. Thompson,et al.  A FluoPol-ABPP PAD2 High-Throughput Screen Identifies the First Calcium Site Inhibitor Targeting the PADs , 2014, ACS chemical biology.

[57]  Toshiyuki Shimizu,et al.  Structural basis for Ca2+-induced activation of human PAD4 , 2004, Nature Structural &Molecular Biology.

[58]  Michael J. Bolt,et al.  Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation , 2012, Proceedings of the National Academy of Sciences.

[59]  Sharmistha Pal,et al.  Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells , 2008, Molecular and Cellular Biology.

[60]  M. Yamada,et al.  Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV , 2005, FEBS letters.

[61]  A. Imbalzano,et al.  Protein Arginine Methyltransferase 7 Regulates Cellular Response to DNA Damage by Methylating Promoter Histones H2A and H4 of the Polymerase δ Catalytic Subunit Gene, POLD1* , 2012, The Journal of Biological Chemistry.

[62]  S. Clarke,et al.  Mechanistic studies on transcriptional coactivator protein arginine methyltransferase 1. , 2011, Biochemistry.

[63]  M. Yamada,et al.  Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. , 2005, Biochemistry.

[64]  Robert E Collins,et al.  Structural and sequence motifs of protein (histone) methylation enzymes. , 2005, Annual review of biophysics and biomolecular structure.

[65]  Yingming Zhao,et al.  JMJD6 Is a Histone Arginine Demethylase , 2007, Science.

[66]  J. Côté,et al.  Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells , 2012, Cell cycle.

[67]  Chuan Li,et al.  Evolutionarily conserved protein arginine methyltransferases in non‐mammalian animal systems , 2012, The FEBS journal.

[68]  J. Wong,et al.  A Role for CARM1-Mediated Histone H3 Arginine Methylation in Protecting Histone Acetylation by Releasing Corepressors from Chromatin , 2012, PloS one.

[69]  Xing Zhang,et al.  Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. , 2003, Structure.

[70]  Aiping Zhang,et al.  Crystal structure of the human PRMT5:MEP50 complex , 2012, Proceedings of the National Academy of Sciences.

[71]  A. Fukamizu,et al.  Protein arginine methyltransferase 7 has a novel homodimer‐like structure formed by tandem repeats , 2014, FEBS letters.

[72]  P. Thompson,et al.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. , 2010, Biochemistry.

[73]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. , 2013, The Journal of clinical investigation.

[74]  O. Acevedo,et al.  A Remodeled Protein Arginine Methyltransferase 1 (PRMT1) Generates Symmetric Dimethylarginine* , 2014, The Journal of Biological Chemistry.

[75]  M. Zernicka-Goetz,et al.  Histone arginine methylation regulates pluripotency in the early mouse embryo , 2007, Nature.

[76]  M. Hottiger ADP‐ribosylation of histones by ARTD1: An additional module of the histone code? , 2011, FEBS letters.

[77]  X. Zheng DNase, ADAMTS13, and iPAD4: good for the heart. , 2014, Blood.

[78]  M. V. van Boekel,et al.  Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value , 2001, Arthritis research.

[79]  S. Richard,et al.  Tudor Domains Bind Symmetrical Dimethylated Arginines* , 2005, Journal of Biological Chemistry.

[80]  R. Frye,et al.  Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.

[81]  Shen-Liang Chen,et al.  The Coactivator-associated Arginine Methyltransferase Is Necessary for Muscle Differentiation , 2002, The Journal of Biological Chemistry.

[82]  PRMT5 is Required for Human Embryonic Stem Cell Proliferation But Not Pluripotency , 2014, Stem Cell Reviews and Reports.

[83]  Paul R Thompson,et al.  Kinetic mechanism of protein arginine methyltransferase 1. , 2008, Biochemistry.

[84]  B Tidor,et al.  Arginine-mediated RNA recognition: the arginine fork , 1991, Science.

[85]  A. Goffeau,et al.  Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae. , 1990, The Journal of biological chemistry.

[86]  P. Thompson,et al.  Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors. , 2012, ACS chemical biology.

[87]  Guido Marcucci,et al.  Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. , 2014, Cancer research.

[88]  I. Miyahara,et al.  Structures of Argininosuccinate Synthetase in Enzyme-ATP Substrates and Enzyme-AMP Product Forms , 2003, Journal of Biological Chemistry.

[89]  M. Waters,et al.  Arginine methylation in a β-hairpin peptide: Implications for Arg-π interactions, ΔCp°, and the cold denatured state , 2006 .

[90]  T. Richmond,et al.  Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.

[91]  D. Wagner,et al.  Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice , 2013, Proceedings of the National Academy of Sciences.

[92]  Heather L. Rust,et al.  A combinatorial approach to characterize the substrate specificity of protein arginine methyltransferase 1. , 2011, Molecular bioSystems.

[93]  F. Mastronardi,et al.  Peptidylarginine deiminase: a candidate factor in demyelinating disease , 2002, Journal of neurochemistry.

[94]  M. Radic,et al.  Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  C. Sardet,et al.  Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene , 2006, Proceedings of the National Academy of Sciences.

[96]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[97]  W. Ellington,et al.  Evolution and physiological roles of phosphagen systems. , 2001, Annual review of physiology.

[98]  Sergio E. Wong,et al.  Strengths of hydrogen bonds involving phosphorylated amino acid side chains. , 2007, Journal of the American Chemical Society.

[99]  C. Allis,et al.  Proteolytic processing of histone H3 in chromatin: a physiologically regulated event in tetrahymena micronuclei , 1980, Cell.

[100]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[101]  A. Yoshiki,et al.  Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. , 2000, The Journal of investigative dermatology.

[102]  Jian Jin,et al.  An allosteric inhibitor of protein arginine methyltransferase 3. , 2012, Structure.

[103]  M. Machius,et al.  Structural basis of histone demethylation by LSD1 revealed by suicide inactivation , 2007, Nature Structural &Molecular Biology.

[104]  J. Côté,et al.  The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. , 2007, Molecular cell.

[105]  Jinxiang Han,et al.  Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors , 2006, Molecular carcinogenesis.

[106]  Wolfgang Knecht,et al.  Structure of the Bacillus subtilis D-aminopeptidase DppA reveals a novel self-compartmentalizing protease , 2001, Nature Structural Biology.

[107]  M. Mann,et al.  Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing , 2009, Science.

[108]  Jianping Lin,et al.  Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine. , 2015, Journal of molecular graphics & modelling.

[109]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[110]  K. Elkon,et al.  Type I IFN system in the development and manifestations of SLE , 2012, Current opinion in rheumatology.

[111]  W. Sippl,et al.  Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. , 2011, Bioorganic & medicinal chemistry.

[112]  A. Ishigami,et al.  Molecular Characterization of Peptidylarginine Deiminase in HL-60 Cells Induced by Retinoic Acid and 1α,25-Dihydroxyvitamin D3 * , 1999, The Journal of Biological Chemistry.

[113]  Yang Shi,et al.  Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.

[114]  C. Jung,et al.  Differential CARM1 expression in prostate and colorectal cancers , 2010, BMC Cancer.

[115]  K. Nomura Specificity and mode of action of the muscle-type protein-arginine deiminase. , 1992, Archives of biochemistry and biophysics.

[116]  P. Vallance,et al.  Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase , 2001, Nature Structural Biology.

[117]  Heike Brand,et al.  Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.

[118]  D. A. Dougherty,et al.  The Cationminus signpi Interaction. , 1997, Chemical reviews.

[119]  M. Bedford,et al.  Protein arginine methyltransferases and cancer , 2012, Nature Reviews Cancer.

[120]  Reinout Raijmakers,et al.  Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. , 2007, Journal of molecular biology.

[121]  Toshiyuki Shimizu,et al.  Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[122]  Pamela A. Silver,et al.  The structure and oligomerization of the yeast arginine methyltransferase, Hmt1 , 2000, Nature Structural Biology.

[123]  C. D. Krause,et al.  FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. , 2006, Biochemical and biophysical research communications.

[124]  P. Thompson,et al.  Protein arginine deiminase 4: evidence for a reverse protonation mechanism. , 2007, Biochemistry.

[125]  L. Pray At the flick of a switch: epigenetic drugs. , 2008, Chemistry & biology.

[126]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[127]  Min Jae Lee,et al.  RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[128]  C. Allis,et al.  Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.

[129]  S. Pang,et al.  Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). , 2008, Bioorganic & medicinal chemistry letters.

[130]  Yusuke Nakamura,et al.  Regulation of histone modification and chromatin structure by the p53–PADI4 pathway , 2012, Nature Communications.

[131]  Robert A. Copeland,et al.  Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.

[132]  James E. Bray,et al.  Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity , 2007, Nature.

[133]  Steven Clarke,et al.  PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins* , 2001, The Journal of Biological Chemistry.

[134]  P. Thompson,et al.  Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion. , 2014, Biochemistry.

[135]  C. Ackerley,et al.  Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis , 2012, Disease Models & Mechanisms.

[136]  W. Robinson,et al.  N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis , 2011, The Journal of Immunology.

[137]  Lang Li,et al.  Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status , 2004, Cancer.

[138]  Sharmistha Pal,et al.  Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.

[139]  C. Allis,et al.  Histone arginine methylation and its dynamic regulation. , 2006, Frontiers in bioscience : a journal and virtual library.

[140]  A. Monzingo,et al.  Characterization of C‐Alkyl Amidines as Bioavailable Covalent Reversible Inhibitors of Human DDAH‐1 , 2011, ChemMedChem.

[141]  E. Stone,et al.  Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase. , 2005, Biochemistry.

[142]  S. Clarke,et al.  δ-N-Methylarginine Is a Novel Posttranslational Modification of Arginine Residues in Yeast Proteins* , 1998, The Journal of Biological Chemistry.

[143]  Hugh Rosen,et al.  Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization. , 2012, ACS chemical biology.

[144]  Joan M Hevel,et al.  Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm. , 2008, Biochemistry.

[145]  Sandra K. Wittmann,et al.  PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation , 2014, Nature Communications.

[146]  B. Garcia,et al.  Methylation of H2AR29 is a novel repressive PRMT6 target , 2011, Epigenetics & Chromatin.

[147]  M. Moscarello,et al.  A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. , 1998, Biochimica et biophysica acta.

[148]  Cheng Luo,et al.  Theoretical Insights into Catalytic Mechanism of Protein Arginine Methyltransferase 1 , 2013, PloS one.

[149]  P. Thompson,et al.  Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate c-Fos Expression in Breast Cancer Cells , 2011, PLoS genetics.

[150]  Yuan Luo,et al.  Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. , 2006, Biochemistry.

[151]  P. Thompson,et al.  Activity-based protein profiling of protein arginine methyltransferase 1. , 2011, ACS chemical biology.

[152]  H. Bull,et al.  Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity , 2013, Science Translational Medicine.

[153]  D. Wagner,et al.  Thrombosis: tangled up in NETs. , 2014, Blood.

[154]  P. Thompson,et al.  Targeting the arginine phosphatase YwlE with a catalytic redox-based inhibitor. , 2013, ACS chemical biology.

[155]  Ulf Reimer,et al.  Histone H2A and H4 N-terminal Tails Are Positioned by the MEP50 WD Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase* , 2015, The Journal of Biological Chemistry.

[156]  Jorng-Tzong Horng,et al.  Incorporating structural characteristics for identification of protein methylation sites , 2009, J. Comput. Chem..

[157]  J. Karn,et al.  Distribution of NG, NG,-dimethylarginine in nuclear protein fractions. , 1977, Biochemical and biophysical research communications.

[158]  N. L. La Thangue,et al.  HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications , 2012, Immunology and cell biology.

[159]  J. Yates,et al.  PRMT5 modulates the metabolic response to fasting signals , 2013, Proceedings of the National Academy of Sciences.

[160]  S. Emamzadah,et al.  Crystal Structure of a Multidomain Human p53 Tetramer Bound to the Natural CDKN1A (p21) p53-Response Element , 2011, Molecular Cancer Research.

[161]  P. Tsao,et al.  Asymmetrical Dimethylarginine in Renal Disease: Limits of Variation or Variation Limits? , 2007, American Journal of Nephrology.

[162]  M. Hu,et al.  Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[163]  Robert L Moritz,et al.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing , 2009, Nature Structural &Molecular Biology.

[164]  Steven M. Johnson,et al.  Determinants of nucleosome organization in primary human cells , 2011, Nature.

[165]  Randall W King,et al.  Small Molecule Regulators of Protein Arginine Methyltransferases* , 2004, Journal of Biological Chemistry.

[166]  Tony Pawson,et al.  Deciphering arginine methylation: Tudor tells the tale , 2011, Nature Reviews Molecular Cell Biology.

[167]  R. Seifert,et al.  Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. , 2008, Journal of medicinal chemistry.

[168]  Michael R. Lindberg,et al.  PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps , 2010, The Journal of experimental medicine.

[169]  Terrence J Sejnowski,et al.  Calcium Green FlAsH as a genetically targeted small-molecule calcium indicator. , 2007, Nature chemical biology.

[170]  P. Thompson,et al.  Mechanistic Studies of Protein Arginine Deiminase 2: Evidence for a Substrate-Assisted Mechanism , 2014, Biochemistry.

[171]  P. Thompson,et al.  Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. , 2005, Biochemistry.

[172]  C. A. Lewis,et al.  The nonenzymatic decomposition of guanidines and amidines. , 2014, Journal of the American Chemical Society.

[173]  P. Thompson,et al.  Protein arginine deiminase 4: a target for an epigenetic cancer therapy , 2011, Cellular and Molecular Life Sciences.

[174]  T. Miranda,et al.  PRMT7 Is a Member of the Protein Arginine Methyltransferase Family with a Distinct Substrate Specificity* , 2004, Journal of Biological Chemistry.

[175]  David M. Wilson,et al.  Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation , 2015, Nature chemical biology.

[176]  Yuan Luo,et al.  The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors. , 2011, Journal of medicinal chemistry.

[177]  M. Gross,et al.  Protein Arginine Deiminase 2 Binds Calcium in an Ordered Fashion: Implications for Inhibitor Design , 2015, ACS chemical biology.

[178]  S. Smith,et al.  The world according to PARP. , 2001, Trends in biochemical sciences.

[179]  J. Hevel,et al.  Substrate-induced control of product formation by protein arginine methyltransferase 1. , 2013, Biochemistry.

[180]  S. Blethen Kinetic properties of the arginine kinase isoenzymes of Limulus polyphemus. , 1972, Archives of biochemistry and biophysics.

[181]  E. Wahle,et al.  Peptide backbone conformation affects the substrate preference of protein arginine methyltransferase I. , 2012, Biochemistry.

[182]  M. Jansson,et al.  Arginine methylation regulates the p53 response , 2008, Nature Cell Biology.

[183]  C. Langford,et al.  CARM1 Is Required in Embryonic Stem Cells to Maintain Pluripotency and Resist Differentiation , 2009, Stem cells.

[184]  Yuan Luo,et al.  Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors. , 2008, Bioorganic & medicinal chemistry.

[185]  Yanming Wang,et al.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. , 2013, Biochimica et biophysica acta.

[186]  P. Thompson,et al.  Kinetic Mechanism of Protein Arginine Methyltransferase 6 (PRMT6)* , 2012, The Journal of Biological Chemistry.

[187]  Yusuke Nakamura,et al.  Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. , 2009, Cancer research.

[188]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[189]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[190]  Xin Wu,et al.  Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors , 2013, Diagnostic Pathology.

[191]  K. Mechtler,et al.  McsB Is a Protein Arginine Kinase That Phosphorylates and Inhibits the Heat-Shock Regulator CtsR , 2009, Science.

[192]  Jing Hu,et al.  Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity* , 2012, The Journal of Biological Chemistry.

[193]  Andrew J. Bannister,et al.  Regulation of chromatin by histone modifications , 2011, Cell Research.

[194]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[195]  L. Burzio,et al.  ADP ribosylation of rat liver nucleosomal core histones. , 1979, The Journal of biological chemistry.

[196]  C. Wolberger,et al.  Structure-based Mechanism of ADP-ribosylation by Sirtuins , 2009, The Journal of Biological Chemistry.

[197]  M. Yamada,et al.  Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes* , 2002, The Journal of Biological Chemistry.

[198]  A. Vaughan,et al.  Stimulation of a Ca2+-Calmodulin-activated Histone 3 Arginine Kinase in Quiescent Rat Heart Endothelial Cells Compared to Actively Dividing Cells (*) , 1995, The Journal of Biological Chemistry.

[199]  R. Lehmann,et al.  Structural basis for methylarginine-dependent recognition of Aubergine by Tudor. , 2010, Genes & development.

[200]  M. Radic,et al.  Histone Deimination As a Response to Inflammatory Stimuli in Neutrophils1 , 2008, The Journal of Immunology.

[201]  G. Golderer,et al.  ADP-ribosylation of core histones and their acetylated subspecies. , 1991, The Biochemical journal.

[202]  A. Ishigami,et al.  Subcellular Localization of Peptidylarginine Deiminase 2 and Citrullinated Proteins in Brains of Scrapie-Infected Mice: Nuclear Localization of PAD2 and Membrane Fraction-Enriched Citrullinated Proteins , 2011, Journal of neuropathology and experimental neurology.

[203]  K. Mechtler,et al.  Studying the fragmentation behavior of peptides with arginine phosphorylation and its influence on phospho‐site localization , 2013, Proteomics.

[204]  P. W. Codding,et al.  Structural studies of duck delta2 crystallin mutants provide insight into the role of Thr161 and the 280s loop in catalysis. , 2004, The Biochemical journal.

[205]  M. Stallcup,et al.  A Chloroacetamidine‐Based Inactivator of Protein Arginine Methyltransferase 1: Design, Synthesis, and In Vitro and In Vivo Evaluation , 2010, Chembiochem : a European journal of chemical biology.

[206]  C. Supuran,et al.  Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[207]  A. Suzuki,et al.  Citrullination by Peptidylarginine Deiminase in Rheumatoid Arthritis , 2007, Annals of the New York Academy of Sciences.

[208]  Y. Wolf,et al.  Global Analysis of Posttranslational Protein Arginylation , 2007, PLoS biology.

[209]  Xing Zhang,et al.  Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis. , 2007, Biochemistry.

[210]  P. Thompson,et al.  Haloacetamidine‐Based Inactivators of Protein Arginine Deiminase 4 (PAD4): Evidence that General Acid Catalysis Promotes Efficient Inactivation , 2010, Chembiochem : a European journal of chemical biology.

[211]  S. Li,et al.  Superbinder SH2 Domains Act as Antagonists of Cell Signaling , 2012, Science Signaling.

[212]  W. Warburton,et al.  549. The basic strengths of methylated guanidines , 1951 .

[213]  M. Esteller Epigenetics in cancer. , 2008, The New England journal of medicine.

[214]  Yuan Luo,et al.  Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4 , 2008, Molecular and Cellular Biology.

[215]  P. Thompson,et al.  Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. , 2009, Current opinion in drug discovery & development.

[216]  S. Khorasanizadeh The Nucleosome From Genomic Organization to Genomic Regulation , 2004, Cell.

[217]  Mark T Bedford,et al.  Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression , 2005, The EMBO journal.

[218]  R. Cole,et al.  Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. , 2010, Arthritis and rheumatism.

[219]  P. Thompson,et al.  Chemical and biological methods to detect post‐translational modifications of arginine , 2014, Biopolymers.

[220]  Nicholas M. Luscombe,et al.  Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..

[221]  J. Wurtz,et al.  Structural insight into arginine methylation by the mouse protein arginine methyltransferase 7: a zinc finger freezes the mimic of the dimeric state into a single active site. , 2014, Acta crystallographica. Section D, Biological crystallography.

[222]  T. Kumarevel,et al.  Crystal structure of the nucleosome core particle , 2015 .

[223]  Michael J. Guertin,et al.  Targeted H3R26 Deimination Specifically Facilitates Estrogen Receptor Binding by Modifying Nucleosome Structure , 2014, PLoS genetics.

[224]  Hongtao Yu,et al.  Structural insights into histone lysine demethylation. , 2010, Current opinion in structural biology.

[225]  S. Morris Regulation of enzymes of the urea cycle and arginine metabolism. , 2002, Annual review of nutrition.

[226]  D. Notterman,et al.  The p53 tumor suppressor gene. , 1994, The Journal of laboratory and clinical medicine.

[227]  C. Muchardt,et al.  Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression , 2012, PLoS genetics.

[228]  M. S. Chapman,et al.  The Putative Catalytic Bases Have, at Most, an Accessory Role in the Mechanism of Arginine Kinase* , 2003, Journal of Biological Chemistry.

[229]  S. Rajski,et al.  Design, Synthesis, and Preliminary Biological Evaluation of a DNA Methyltransferase‐Directed Alkylating Agent , 2006, Chembiochem : a European journal of chemical biology.

[230]  Deepak Poudyal,et al.  Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[231]  S. Clarke,et al.  Protein arginine methylation in mammals: who, what, and why. , 2009, Molecular cell.

[232]  J. Yates,et al.  Arginylation and methylation double up to regulate nuclear proteins and nuclear architecture in vivo. , 2011, Chemistry & biology.

[233]  Jing Zhong,et al.  Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer. , 2011, Gene.

[234]  Tony Kouzarides,et al.  SnapShot: Histone-Modifying Enzymes , 2007, Cell.

[235]  M. Feldmann,et al.  Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis , 2010, Immunological reviews.

[236]  Sharmistha Pal,et al.  mSin3A/Histone Deacetylase 2- and PRMT5-Containing Brg1 Complex Is Involved in Transcriptional Repression of the Myc Target Gene cad , 2003, Molecular and Cellular Biology.

[237]  W. Kidwell,et al.  Properties of the complex between histone H1 and poly(ADP-ribose synthesised in HeLa cell nuclei. , 1977, European journal of biochemistry.

[238]  S. Liang,et al.  TDRD3 is an effector molecule for arginine-methylated histone marks. , 2010, Molecular cell.

[239]  J. Bilbao,et al.  Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein , 1996, Annals of neurology.

[240]  G. Muscat,et al.  CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells. , 2012, The Biochemical journal.

[241]  Xavier Robert,et al.  Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..

[242]  Ronald W. Davis,et al.  A high-resolution atlas of nucleosome occupancy in yeast , 2007, Nature Genetics.

[243]  L. A. Bush,et al.  ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. , 2003, Developmental biology.

[244]  Steven J Brown,et al.  A fluopol-ABPP HTS assay to identify PAD inhibitors. , 2010, Chemical communications.

[245]  Q. Gong,et al.  Structural determinants for the strict monomethylation activity by trypanosoma brucei protein arginine methyltransferase 7. , 2014, Structure.

[246]  Dino Moras,et al.  Functional insights from structures of coactivator‐associated arginine methyltransferase 1 domains , 2007, The EMBO journal.

[247]  Benjamin A Garcia,et al.  Proteomic characterization of novel histone post-translational modifications , 2013, Epigenetics & Chromatin.

[248]  C. D. Krause,et al.  Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. , 2007, Pharmacology & therapeutics.

[249]  Ted M. Lakowski,et al.  A Kinetic Study of Human Protein Arginine N-Methyltransferase 6 Reveals a Distributive Mechanism* , 2008, Journal of Biological Chemistry.

[250]  Ailan Guo,et al.  PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145 , 2015, Nature Communications.

[251]  C. Ackerley,et al.  Peptidylarginine deiminase 2 ( PAD 2 ) overexpression in transgenic mice leads to myelin loss in the central nervous system , 2022 .

[252]  Steven Clarke,et al.  Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination , 2004, Science.

[253]  P. Li,et al.  Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression , 2010, Oncogene.

[254]  A. Imbalzano,et al.  Protein arginine methyltransferase 5 (Prmt5) promotes gene expression of peroxisome proliferator-activated receptor γ2 (PPARγ2) and its target genes during adipogenesis. , 2012, Molecular endocrinology.

[255]  Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase , 2013 .

[256]  B. Wang,et al.  Discovery and mechanistic study of a class of protein arginine methylation inhibitors. , 2010, Journal of medicinal chemistry.

[257]  Steven R. Shave,et al.  Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening , 2012, BMC Bioinformatics.

[258]  G. Chang,et al.  Chemical mechanism of the endogenous argininosuccinate lyase activity of duck lens delta2-crystallin. , 1998, The Biochemical journal.

[259]  E. Kremmer,et al.  Arginine methylation next to the PY‐NLS modulates Transportin binding and nuclear import of FUS , 2012, The EMBO journal.

[260]  K. Mizuguchi,et al.  A novel superfamily of enzymes that catalyze the modification of guanidino groups. , 2001, Trends in biochemical sciences.

[261]  Biao-yang Lin,et al.  A Novel Histone H4 Arginine 3 Methylation-sensitive Histone H4 Binding Activity and Transcriptional Regulatory Function for Signal Recognition Particle Subunits SRP68 and SRP72* , 2012, The Journal of Biological Chemistry.

[262]  Bryan J. Venters,et al.  Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis* , 2008, Journal of Biological Chemistry.

[263]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice , 2014, Annals of the rheumatic diseases.

[264]  C. Allis,et al.  Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. , 2007, Molecular cell.

[265]  Timothy L Bailey,et al.  Defining the RGG/RG motif. , 2013, Molecular cell.

[266]  H. Ruley,et al.  Arginine N-Methyltransferase 1 Is Required for Early Postimplantation Mouse Development, but Cells Deficient in the Enzyme Are Viable , 2000, Molecular and Cellular Biology.

[267]  S. Clarke,et al.  The Novel Human Protein Arginine N-Methyltransferase PRMT6 Is a Nuclear Enzyme Displaying Unique Substrate Specificity* , 2002, The Journal of Biological Chemistry.

[268]  Kerstin Neubert,et al.  DRE-1: an evolutionarily conserved F box protein that regulates C. elegans developmental age. , 2007, Developmental cell.

[269]  J. G. Hirsch BACTERICIDAL ACTION OF HISTONE , 1958, The Journal of experimental medicine.

[270]  David Baker,et al.  Quantitative reactivity profiling predicts functional cysteines in proteomes , 2010, Nature.

[271]  Zongyang Lv,et al.  Structural insights into protein arginine symmetric dimethylation by PRMT5 , 2011, Proceedings of the National Academy of Sciences.

[272]  Xiaojiang Xu,et al.  Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression , 2010, BMC Bioinformatics.

[273]  András Falus,et al.  Citrullination: a posttranslational modification in health and disease. , 2006, The international journal of biochemistry & cell biology.

[274]  A. Scorilas,et al.  Clinical evaluation of PRMT1 gene expression in breast cancer , 2011, Tumor Biology.

[275]  Wei Hong,et al.  Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases. , 2010, Bioorganic & medicinal chemistry letters.

[276]  E. Stone,et al.  Substrate-assisted cysteine deprotonation in the mechanism of dimethylargininase (DDAH) from Pseudomonas aeruginosa. , 2006, Biochemistry.

[277]  B. Wakim,et al.  Ca(2+)-calmodulin-dependent phosphorylation of arginine in histone 3 by a nuclear kinase from mouse leukemia cells. , 1994, The Journal of biological chemistry.

[278]  J. Cooke,et al.  Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. , 2003, Atherosclerosis. Supplements.

[279]  M. S. Chapman,et al.  Transition state structure of arginine kinase: implications for catalysis of bimolecular reactions. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[280]  P. Trojer,et al.  A novel arginine methyltransferase inhibitor with cellular activity. , 2007, Bioorganic & medicinal chemistry letters.

[281]  R. Blumenthal,et al.  Many paths to methyltransfer: a chronicle of convergence. , 2003, Trends in biochemical sciences.

[282]  I. Treilleux,et al.  Regulation of estrogen rapid signaling through arginine methylation by PRMT1. , 2008, Molecular cell.

[283]  K. Sugawara,et al.  Properties of peptidylarginine deiminase from the epidermis of newborn rats. , 1981, Journal of biochemistry.

[284]  Ted M. Lakowski,et al.  Peptidic Partial Bisubstrates as Inhibitors of the Protein Arginine N‐Methyltransferases , 2011, Chembiochem : a European journal of chemical biology.

[285]  Troy E. Sandberg,et al.  Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming ω-NG-Monomethylated Arginine Residues* , 2012, The Journal of Biological Chemistry.

[286]  K. Kehn-Hall,et al.  Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function , 2010, PLoS ONE.

[287]  Jens Böse,et al.  Analysis of Jmjd6 Cellular Localization and Testing for Its Involvement in Histone Demethylation , 2010, PloS one.

[288]  Kun Qian,et al.  Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1 , 2014, Journal of medicinal chemistry.

[289]  Heather L. Rust Decoding PRMT1: Studies On the Catalytic Mechanism, Regulation, Inhibition, and Crosstalk of PRMT1-Dependent Methylation , 2013 .

[290]  D. Aswad,et al.  Regulation of transcription by a protein methyltransferase. , 1999, Science.

[291]  A. Varshavsky,et al.  The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators , 2005, Nature.

[292]  Jun Li,et al.  CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. , 2011, Cancer research.

[293]  S. Khorasanizadeh,et al.  Recognition of trimethyllysine by a chromodomain is not driven by the hydrophobic effect , 2007, Proceedings of the National Academy of Sciences.

[294]  Xiaodong Cheng,et al.  Crystal structure of the conserved core of protein arginine methyltransferase PRMT3 , 2000, The EMBO journal.

[295]  Guang-Yaw Liu,et al.  Functional Role of Dimerization of Human Peptidylarginine Deiminase 4 (PAD4) , 2011, PloS one.

[296]  Paul Tempst,et al.  Histone Deimination Antagonizes Arginine Methylation , 2004, Cell.

[297]  A. Chumanevich,et al.  Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. , 2012, Journal of the American Chemical Society.

[298]  P. Trojer,et al.  Target-based approach to inhibitors of histone arginine methyltransferases. , 2007, Journal of medicinal chemistry.

[299]  Mark T Bedford,et al.  Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.

[300]  E. Vossenaar,et al.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[301]  M. Bedford,et al.  Histone arginine methylation , 2011, FEBS letters.

[302]  O. Griffith,et al.  Identification of PADI2 as a potential breast cancer biomarker and therapeutic target , 2012, BMC Cancer.

[303]  C. Allis,et al.  Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.

[304]  Thomas W. Linsky,et al.  Guanidine-modifying enzymes in the pentein superfamily , 2010 .

[305]  H R Herschman,et al.  PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[306]  M. Cleary,et al.  Protein arginine-methyltransferase-dependent oncogenesis , 2007, Nature Cell Biology.

[307]  H. Erdjument-Bromage,et al.  Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.

[308]  Yuan Luo,et al.  A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation. , 2006, Journal of the American Chemical Society.

[309]  Yusuke Nakamura,et al.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.

[310]  H. Kessler Detection of Hindered Rotation and Inversion by NMR Spectroscopy , 1970 .

[311]  P. Thompson,et al.  Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis , 2014, Circulation research.

[312]  D. Fessas,et al.  Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins , 2011, Nature Structural &Molecular Biology.

[313]  G. Stark,et al.  PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB , 2013, Proceedings of the National Academy of Sciences.

[314]  J. Moss,et al.  Molecular and immunological characterization of ADP-ribosylarginine hydrolases. , 1992, The Journal of biological chemistry.